Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
1.800
+0.050 (2.86%)
Sep 16, 2025, 3:10 PM EDT - Market open

MTNB Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for MTNB.

Price Target: $ (0.00%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

According to 1 stock analyst, the rating for MTNB is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMay '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy222220
Buy000000
Hold000001
Sell000000
Strong Sell000000
Total222221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 31, 2024
BTIG
BTIG
Strong Buy
Initiates
$150
Strong BuyInitiates$150+8,233.33%Oct 11, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong BuyReiterates$150+8,233.33%Jan 31, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$150
BuyInitiates$150+8,233.33%Jan 27, 2020
SunTrust Robinson Humphrey
SunTrust Robinson Humphrey
Strong Buy
Initiates
$150
Strong BuyInitiates$150+8,233.33%Jan 24, 2020
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.53
from -4.98
EPS Next Year
-5.10
from -1.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
158.33K33.00K3.19M1.10M---
Revenue Growth
76.29%-79.16%9,560.61%-65.62%---
EPS
-5.90-5.63-4.84-5.28-4.98-1.53-5.10
EPS Growth
-------
Forward PE
-------
No. Analysts
-----34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027
High--
Avg--
Low--

EPS Forecast

EPS202520262027
High-1.58-4.20
Avg-1.53-5.10
Low-1.47-5.88

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.